Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Tuesday that the Royal Brisbane and Women's Hospital (RBWH) has replaced its former photon planning system with the company's treatment planning system RayStation.
This order was received and mainly generated revenues within the fourth quarter of 2019, exact financial details of which were not available.
Reportedly, the adaptive workflow functionality and multi-criteria optimisation capabilities of RayStation will help sustain RBWHs position as one of the region's most-advanced treatment centres. RBWH is the largest medical facility in Queensland, Australia, employing over 8,000 multidisciplinary staff across a range of clinical areas. The hospital is known for its preeminent cancer treatment using a broad spectrum of advanced treatment types.
According to the company, RayStation will provide RBWH oncology specialists with innovative tools to treat different cancer types in the most-efficient and precise way possible with its Varian treatment machines.
RaySearch is a developer of software solutions to improve cancer care. It markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption